Skip to main
MYO

Myomo (MYO) Stock Forecast & Price Target

Myomo (MYO) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Myomo Inc has demonstrated a consistent growth trajectory in its reimbursement pipeline, increasing from 1,389 units in Q4 to 1,669 units in the latest quarter, highlighting an upward trend in demand for its myoelectric orthotics. The company is strategically redirecting its focus towards the expansive Medicare market, which is expected to significantly bolster revenue, particularly as O&P providers are projected to contribute approximately 22% of total revenue in 2024. Furthermore, the recent favorable ruling from CMS to include the MyoPro under Medicare Part B benefits substantially broadens Myomo's market potential, positioning the company for enhanced financial performance moving forward.

Bears say

Myomo Inc. has significantly lowered its 2025 revenue guidance from a range of $50–53 million to $40–42 million, indicating potential operational challenges ahead. Additionally, a decline in the backlog of insurance-authorized devices, dropping from 272 in Q4 to 208, reflects a concerning trend in the company's sales pipeline and demand for their products. The company's recent marketing effectiveness and lead conversion rates have underperformed expectations, suggesting a weakened competitive position and raising concerns regarding future revenue growth.

Myomo (MYO) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Myomo (MYO) Forecast

Analysts have given Myomo (MYO) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Myomo (MYO) has a Strong Buy consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Myomo (MYO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.